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Abstract
The binding reaction of the biomolecules streptavidin and anti-biotin antibody, both labelled by
magnetic nanoparticles (MNP), to biotin coated on agarose beads, was quantified by
magnetorelaxometry (MRX). Highly sensitive SQUID-based MRX revealed the immobilization of
the MNP caused by the biotin-streptavidin coupling. We found that about 85% of streptavidin-
functionalised MNP bound specifically to biotin-agarose beads. On the other hand only 20% of
antibiotin-antibody functionalised MNP were specifically bound. Variation of the suspension
medium revealed in comparison to phosphate buffer with 0.1% bovine serum albumin a slight
change of the binding behaviour in human serum, probably due to the presence of functioning (non
heated) serum proteins. Furthermore, in human serum an additional non-specific binding occurs,
being independent from the serum protein functionality.
The presented homogeneous bead based assay is applicable in simple, uncoated vials and it enables
the assessment of the binding kinetics in a volume without liquid flow. The estimated association
rate constant for the MNP-labelled streptavidin is by about two orders of magnitude smaller than
the value reported for free streptavidin. This is probably due to the relatively large size of the
magnetic markers which reduces the diffusion of streptavidin. Furthermore, long time non-
exponential kinetics were observed and interpreted as agglutination of the agarose beads.
Background
The binding reaction between different biomolecules, e.g.
antibody-protein or ligand-receptor coupling, is of great
interest in traditional and in modern fields of biosciences,
e.g. proteomics. For example, the kinetics of association
and dissociation reactions enables the estimation of the
affinity of biomolecules. This is useful for studies on drug
efficiency or therapeutic drug monitoring [1].
The detection and quantification of antigenes, e.g. specific
surface proteins of bacteria or malignant cells, or specific
extraneous biomolecules, is performed by so-called
immunoassays. In immunoassays, detection molecules,
e.g. antibodies, bind specifically to the analyte to be quan-
tified. Signal transducers which are linked to the detection
molecules give a physically measurable signal.
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In heterogeneous immunoassays, the unbound markers
have to be washed out in order to get a signal from bound
marked detection molecules, only. In homogeneous
immunoassays the signal of the transducers changes as the
result of the binding of the detection molecule, i.e. the
amount of bound detection molecules can be measured
in the presence of unbound ones by separating the two
qualitatively different signals. Besides their high potential
for automation, homogeneous immunoassays enable the
measurement of the binding kinetics [2]. Well-known
examples of homogeneous assays are the Fluorescence
Polarisation Immunoassay (FPIA) [3] and the Surface
Plasmon Resonance (SPR) assay [4,5]. In the case of FPIA
the signal transducers are fluorophores changing the
polarisation of the emitted light after a binding. In the
SPR based assay, the detection molecules are attached to a
solid surface acting as anchors for the analyte molecules.
The binding increases the mass attached to the sensor sur-
face leading to a change of the surface plasmon resonance
frequency.
Another homogeneous immunoassay is the MAgnetic
Relaxation ImmunoAssay (MARIA) [6,7], where the detec-
tion molecules are labelled by magnetic nanoparticles act-
ing as signal transducers.
In this paper we investigate the quantification of the
biotin-streptavidin and biotin-antibiotin-antibody bind-
ings and its kinetics using MARIA. Biotin serves as the ana-
lyte and streptavidin and antibiotin-antibody have the
function of detection molecules.
In MARIA, the detection molecules are labelled by Mag-
netic NanoParticles (MNP). These composites are the
probes for the analyte molecules. The relaxation of the
magnetic moment of the MNP after switching off an exter-
nal field by their relaxation behavior is measured by Mag-
netoRelaXometry (MRX) [8]. The relaxation signal
depends on the binding state of the probes [6]. MARIA
provides the quantity of immobilised probes, i.e. the
amount of bound biomolecules, in the presence of the
unbound ones because these two signal contributions can
be separated. Consequently, MARIA is a homogeneous
immunoassay which needs no washing steps and the
kinetics of the binding is easily accessible. Because the
magnetic signal is not influenced by non-magnetic com-
ponents of biological material, the binding behavior of an
analyte can be investigated in different environments (e.g.
water, serum or blood) with only one method by MARIA.
MARIA does not require a special geometry, so that stand-
ard vials can be used. Thus, it is possible to quantify bio-
molecules in a realistic environment, without severe
sample alterations due to preparation.
MARIA was already used for in-vitro applications, e.g. the
quantification of human IgG [9] or Listeria monocytogenes
[10]. While most early studies [9] utilised a solid phase
immunoassay, we here present the method of a bead
based assay, where the analyte is coupled to µm-sized
beads (agarose beads) (Fig. 1). Thus, specially prepared
reaction vials (e.g. coating with catching antibodies) are
not necessary. Further, the measurement range can be
enhanced because the total reaction surface (bead surface)
can exceed that of the well surface, considerably. In con-
trast to the solid phase assay, here both components are
mobile. This has advantages, for instance the distribution
of the reactants is much more homogeneous. Also, the
reaction kinetics should be faster and more clearly
described than in a solid phase assay, due to less influence
of mass transport phenomena on the binding kinetics. On
the other hand, the present system has more degrees of
freedom on the microscopic scale making it more com-
plex. It arises the problem of a possible agglutination of
the beads driven by the binding. In order to check the
integrity of the method, we address the problem whether
this enhanced complexity influences the feasibility and
the range of linearity of this kind of assay. We investigated
how the relatively large size of the marker affects the bind-
ing efficiency and the binding kinetics. Further, we exam-
ined the influence of the medium on the binding reaction,
comparing the quantity of bound probes in 0.1% bovine
serum albumin and human serum.
Relaxation curves of the MNP*SAV measured 15 min, 1 h, 5  h and 24 h after mixing with biotin-agarose Figure 1
Relaxation curves of the MNP*SAV measured 15 min, 1 h, 5 
h and 24 h after mixing with biotin-agarose. The relaxation 
curves of the control samples (see text) are also depicted. 
The relaxation curve of immobilized MNP (freeze-dried) is 
the reference for completely bound MNP.Journal of Nanobiotechnology 2008, 6:4 http://www.jnanobiotechnology.com/content/6/1/4
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Results and Discussion
Quantification of the binding
First, aqueous suspensions of the magnetic probes alone
were measured to provide a reference for the evaluation of
relaxation changes due to the binding of the particles. In
the absence of a binding target, the observed relaxation
time of the sample moment, τobs, was in the range of 2 ms.
After incubation with biotin-agarose beads the relaxation
time increased to up to 15 ms (Figs 2, 3), indicating the
immobilisation of the MNP by the binding of the detec-
tion molecules to the large targets.
By fitting eq (2) to the measured relaxation curves, the
amount of bound probes MNP*SAV (streptavidin linked
to MNP), β, was calculated. The uncertainty is about 5%.
With elapsing incubation time, tI, β increased (Fig. 4) to a
level of 85%. We obtained similar results even at a 3 times
higher concentration of MNP*SAV (Fig. 5). Thus, we can-
not attribute the presence of 15% unbound MNP*SAV to
a lack of biotin targets, but rather to the signal from idle
MNP labels, e.g., to MNP carrying streptavidin in an inop-
erative configuration or to the presence of MNP which do
not carry streptavidin-molecules at all.
On the other hand, in the control sample, where
MNP*SAV saturated with biotin was incubated with
biotin agarose, the same relaxation signal as that of the
reference sample of MNP*SAV without the biotin agarose
target (Fig. 2) was obtained. This indicates the absence of
unspecific binding, so that the binding between
MNP*SAV and agarose can be attributed exclusively to the
specific streptavidin-biotin coupling.
The binding behaviour of MNP*AB (antibiotin-antibody
linked MNP) to biotin agarose was quantitatively differ-
ent. Even after one day of incubation, only 25% of the
MNP*AB were coupled to the targets (Fig. 4). We obtained
the same result in the case of a 10 times lower concentra-
tion of MNP*AB. Apparently, 75% of the labels are not
immobilized, even in the excess of target molecules. One
explanation might be again that there are MNP-labels
without properly coupled detection molecules. Obvi-
ously, in the case of MNP*AB the fraction of idle labels is
much larger than in the case of MNP*SAV.
The control experiment for MNP*AB again exhibits a
behaviour that is different from MNP*SAV. After incuba-
tion with a high excess of free biotin, part of MNP*AB are
immobilized in the presence of biotin agarose, indicated
by an increased relaxation time, while no change in relax-
ation was observed for the samples without biotin agarose
(Fig. 4). To explain this behaviour we propose two
hypotheses: (i) The MNP*AB bind to the agarose-beads
non-specifically. (ii) The antibiotin antibodies bind read-
Relaxation curves of MNP*AB measured 15 min, 1 h, 5 h and 24 h after mixing with biotin-agarose Figure 2
Relaxation curves of MNP*AB measured 15 min, 1 h, 5 h and 24 h after mixing with biotin-agarose.
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Influence of the MNP*SAV concentration on the binding kinetics Figure 3
Influence of the MNP*SAV concentration on the binding kinetics. Samples were slowly rotated during incubation. The fraction 
of bound MNP*SAV as a function of incubation time is depicted for different MNP-dilution ratios. Solid curves represent the 
best fits according to (16).































Fraction of bound MNP*SAV and MNP*AB as a function of incubation time Figure 4
Fraction of bound MNP*SAV and MNP*AB as a function of incubation time. Subtraction of the amount of non-specific bound 
MNP*AB (control) yields the time dependence of its specific binding (open triangles). The solid lines are curves fitted accord-
ing to (16). Exponential growth functions β(tI) = βmax (1 - exp{-tI/τ}) (dotted lines) are fitted to show the deviation from expo-
nential behavior.




















I / minJournal of Nanobiotechnology 2008, 6:4 http://www.jnanobiotechnology.com/content/6/1/4
Page 5 of 12
(page number not for citation purposes)
ily to biotin being part of larger compartments, e.g. bioti-
nylated proteins, but only modestly to free biotin [11].
This causes the biotin, immobilised to agarose beads, to
exchange the free biotin at the anti-biotin antibody.
Binding kinetics
The continuous measurement of the magnetic relaxation
during the incubation time tI provides information about
the binding kinetics. By fitting equation (16) to the relax-
ation curves, we obtain β(tI) the actual relative amount of
bound MNP. From our data the binding time tb, which is
defined as the time at which β(tb) = (1/(1 - 1/e)) βmax,
where βmax is the amount of bound probes for t → ∞ in the
saturation condition, was estimated to be tb = (9400 ±
1000) s and tb = (3600 ± 350) s for MNP*SAV and
MNP*AB, respectively.
In these binding experiments (Figs 2, 3) the samples were
shaken shortly just before each measurement sequence in
order to homogenise the samples. Between the subse-
quent relaxation measurements that monitored the kinet-
ics of the binding reaction the samples were in rest. In a
second set of experiments the samples were rotated slowly
between each relaxation measurement. With sample rota-
tion, the binding kinetics was found to be faster with tb =
(4400 ± 220) s and tb = (807 ± 100) s for MNP*SAV and
MNP*AB, respectively (Table 1). Shaking and rotating
should prohibit the sedimentation of agarose beads in the
sample, which may hamper the diffusion of MNP*SAV to
the biotin targets. In this way, the observed acceleration of
the binding kinetics can be understood.
As discussed in methodical section, we can calculate the
association rate constants according to (11), which are
listed in Table 1. With the obtained association rate con-
stants equation 11 holds for cP,0 Ŭ kd/ka,p = 10-12  ,
using kd ≈ 10-8 s-1 [12,13]. This condition is fulfilled in all
our experiments (Table 1).
In order to compare these values with those found for
unlabelled streptavidin using SPR, we have first estimated
the values for unlabelled streptavidin using (12). Assum-
mol
l
Relaxation curves for MNP*SAV2 binding to biotin-agarose in different suspension media Figure 5
Relaxation curves for MNP*SAV2 binding to biotin-agarose in different suspension media. The incubation time is tI = 200'. In 
the control sample the SAV2-molecules of the MNP*SAV2 were saturated with free biotin before incubation with analyte sus-
pension.
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ing that the streptavidin molecules (SAV) have a "diame-
ter" of about 10 nm we get a size ratio κ = rP/rSAV = 5
(mean diameter of the MNP*SAV is approximately 50
nm). Accordingly, the association rate constant for bare
streptavidin becomes 3...6·105   depending on the
agitation of the sample (Table 1). These values are one
order below the reported association rate constants for
streptavidin 5·106  [13] and avidin 10·106
[12]. Probably, this discrepancy is connected with
the strong decrease of rotational diffusion (∝  ) of SAV
due to its association with MNP, which is not taken into
account in (12). Furthermore, there is an agglutination of
the agarose beads which may cause a reduction of the
binding kinetics.
Agglutination
The kinetics data β(tI) were well described by fitting a
binding model (14) developed earlier for description the
binding of charged MNP to oppositely charged latex
spheres [14] (see appendix) (Fig. 4 and 5). However, there
is a strong deviation from the expected exponential
behavior (equation 10), represented by the dotted lines,
especially for the non-agitated samples with the
MNP*SAV probes (Fig. 4). Further, the obtained parame-
ters seems to be far from the reality. For instance, the
parameter αF, describing the fraction of binding active sur-
face area of the agarose beads is only in the order of sev-
eral percent.
We attribute this behavior to the agglutination of the aga-
rose beads due to the binding of probes. This view is sup-
ported by the fact that agarose aggregates are visible with
the eye after the binding reaction. This agglutination may
also be responsible for the circumstance that the associa-
tion rate "constant" depends on the concentration (Table
1).
Although the association constant of antibiotin-antibody
to biotin Ka = 109  [15] is much smaller than that of
streptavidin (Ka ≈ 1015  [16]) and although the num-
bers of antibiotin-antibodies per probe seems to be less
than that for streptavidin probes (see above), the kinetics
of MNP*AB-biotin-agarose coupling is in the same range
like that of MNP*SAV-biotin-agarose coupling (Table 1).
We attribute this behavior to a lower degree of agglutina-
tion of biotin-agarose beads by MNP*AB probes, con-
firmed by visual observation of the aggregates, which are
stronger developed in the MNP*SAV samples than in the
MNP*AB samples. This we explain as follows: Only about
20% of the MNP*AB probes bind specifically (see above).
Therefore, we guess that the fraction of MNP to which
more than 1 antibody is attached in the right direction, is
much smaller than in the case of MNP*SAV. Because
solely these MNP having more than one detection mole-
cule can provoke cross-linking among the agarose beads,
there is a lower probability of agglutination of agarose
beads by MNP*AB probes than by MNP*SAV probes. If
agglutination takes place, many binding places becomes
hidden quickly after start of the incubation. Thus, a slow-
ing down of the binding kinetics accompanied by a non-
exponential behavior can be understood.
Influence of the suspension medium
In this section we compare the binding of MNP-probes
suspended in different media, namely BSA-Buffer (BSA-
B), being PBS (phosphat buffered saline) with 0.1% BSA
(bovine serum albumin), and human serum. Because we













Table 1: Values of binding time estimated from the binding curves β(tI) as well as the association rate constants calculated according 
(11), (12) and the association rate constant for free streptavidin, take from [13].
Association rate constant
Samples MNP-concentration cP 
(nmol/1) binding time tb (s) eq. (11) ka  eq. (12) ka 
Ref. [13] ka 
without agitation
MNP*SAV 2 9400 ± 1000 54 ± 9 270 ± 45 5000
MNP*AB 23 3600 ± 350 12 ± 2 60 ± 10
with agitation
MNP*SAV 2 4400 ± 220 116 ± 20 580 ± 100 5000
MNP*SAV 6 2700 ± 60 63 ± 2 315 ± 10 5000
MNP*AB 23 807 ± 100 55 ± 10 275 ± 50
() 10
3 l
mol s () 10
3 l
mol s () 10
3 l
mol sJournal of Nanobiotechnology 2008, 6:4 http://www.jnanobiotechnology.com/content/6/1/4
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agglutination effects in MNP-samples, probably due to
active antibodies [17], we used also tempered serum. The
serum was tempered at 60°C for 40 minutes leading to
cancelling of this reason for agglutination [17].
First, we checked the influence of the suspension medium
on the relaxation signal of the MNP-probes alone. The
relaxation curve for MNP suspended in BSA-buffer is very
similar in shape to that of human serum (Figure 6). But
the relaxation time is by a factor of 1.4 smaller than that
of the serum sample. This difference is related to the vis-
cosity of serum of about 2 mPa s being twice of that of
water: Analysing the relaxation curves with a model
describing the hydrodynamic properties of the MNP [18]
using the mentioned values for the dynamic viscosity, we
get mean hydrodynamic diameters (diameter of objects
with mean volume) of the relaxing entities (MNP and
small clusters) of 76(2) nm, 65(2) nm and 76(2) nm for
MNP suspended in BSA, human serum and tempered
human serum, respectively. As argued above, the serum
components obviously are responsible for a slight change
in the MNP-aggregation in the suspension, represented by
a change of the distribution of hydrodynamic sizes.
Here, it was demonstrated that the relaxation behavior of
MNP can be measured in different media, what was
already done in [18]. The data show, that the same results
were obtained if the differences in the viscosity were taken
into account.
Next, we discuss the binding behaviour in the different
media. By fitting model (2) to the relaxation curves (Fig-
ure 5), we get the fraction of bound probes, β (Table 2).
The results show clearly that there is an additional binding
yield of 26% in the serum sample in comparison to the
BSA-buffer based one. This difference disappears, if the
serum was tempered before use. Therefore, we conclude
that the activity of some serum proteins is responsible for
this additional binding.
The results obtained from the control samples show, that
about 5% and 11% of the probes bind non-specifically in
BSA-B and human serum, respectively. Because MNP*SAV
shows no non-specific binding (Figure 1), we attribute the
occurrence of the nonspecific binding in BSA-B to the
changed batch of MNP-probes MNP*SAV2. However,
serum components are obviously responsible for the
enhancement of this non-specific binding of the
Sketch of the specific binding between streptavidin functionalised MNP and biotin-agarose Figure 6
Sketch of the specific binding between streptavidin functionalised MNP and biotin-agarose. The magnetic nanoparticles (the 
arrow symbolises its moment) have a physical extent mean diameter of d ≈ 50 nm and the diameter of biotin-agarose beads is 
(dA ≈ 5 µm). The large extent of streptavidin (mw = 53000 g/mol) is about 10 nm, whereas the biotin molecule is much smaller 
(mw = 244 g/mol).
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MNP*SAV2 probes by about 6%. Note, that the MRX-
curves of the control samples for serum and tempered
serum are nearly identical. This means, that the non-spe-
cific binding is not related to the functioning of the serum
proteins.
Conclusion
We presented a method for quantification of biomole-
cules in the form of a bead based magnetic relaxation
immunoassay. In a conventional solid phase immu-
noassay the analyte is fixed on the surface of the reaction
well. The area of this active surface of one well (96 well
plate) is 1.5·10-4 m2. In our realised bead based assay the
target surface area is about 1.5·10-3 m2 per well. The agar-
ose beads and thus the target surface is more homogene-
ously distributed in the sample volume than in a solid
phase system, where the analyte has to reach a surface
coated with the detection molecules. Thus, in principle, in
MARIA measurements in arbitrarily shaped volumes are
possible.
Applying this method, we could quantify the binding of
magnetically labelled streptavidin having a concentration
of about 2 nmol/l with an accuracy of about 5% using a
highly sensitive SQUID-measurement system. Given sen-
sitivity was achieved by fitting a relaxation model to the
relaxation data, whereby we could use the data of samples
with fully immobilised MNP as a reference. By means of a
control experiment we have shown that the probes were
immobilised by specific streptavidin-biotin coupling or
predominantly specific antibiotin-antibody-biotin cou-
pling.
In the present assay design the analyte had to fixed to a rel-
atively large bead enabling the detection by MRX. In order
to quantify free analytes, the design has to be realised as a
competition assay. I.e. the free analyte molecules compete
with the bead based ones for the MNP-labelled detection
molecules.
In the presented bead based binding assay the binding
kinetics depends on the sample treatment during the incu-
bation. In order to achieve reproducible kinetics, it is nec-
essary to provide a controlled smooth sample stirring
which prevents sedimentation of the larger beads.
Further, the size of the probes, i.e. MNP-detection mole-
cule complexes, crucially determines the diffusion and
hence the association rate constant. Presumably, the bind-
ing reaction is accompanied by agglutination processes
affecting the binding kinetics. In order to estimate proper
kinetics parameters binding experiments with an excess of
probes have to be realised, suppressing the agglutination
of agarose beads.
Obviously, the use of the large MNP as markers for bio-
molecules makes the estimation of the kinetics of the
binding reaction difficult. However, the MRX method is
suitable for a quantitative check of the functionalisation
of MNP prepared for specific binding to an analyte. This is
an important issue, because the research on systems of
nanoparticles for diagnostic and therapeutical purposes is
strongly increasing. For instance in tumor therapy and
diagnostics (MRI) with MNP the focus tends from simple
core shell MNP to functionalised (e.g. with an antibody)
MNP which should find their target by specific binding
[19]. Therefore, the complex binding behavior which can
be accompanied by nonspecific binding has to be meas-
ured in order to develop such particles or in order to check
its quality by the users.
Methods
The bead based magnetic relaxation binding assay pre-
sented here (Fig. 1) has two peculiarities: (i) MNP that
label the detection molecules have an overall diameter
ranging from 15 nm to 60 nm or even more, i.e. in most
cases the size of the marker is of the order or even larger
than the size of the detection molecules. (ii) The analyte
molecules are bound to beads being large in comparison
to the markers. These two peculiarities make the signals of
bound and unbound markers separable with high sensi-
tivity. Furthermore, free analytes can be quantified by
competition assay, i.e. the free analytes compete with the
bead-associated ones for the binding sites of the probes.
Table 2: Fraction of bound MNP*SAV2 to biotin-agarose beads after an incubation time tI in different suspension media estimated by 
fitting the MRX-curves by (2). The control sample means that SAV-molecules of the MNP*SAV2 are saturated with free biotin before 
incubation with analyte suspension.
Fraction of bound MNP
Agarose beads
Medium tI min no analyte Control Binding
BSA-B 200 0.018 ± 0.006 0.054 ± 0.007 0.61 ± 0.04
serum tempered 200 0.005 ± 0.008 0.117 ± 0.012 0.61 ± 0.04
serum 200 0.011 ± 0.008 0.114 ± 0.009 0.87 ± 0.06Journal of Nanobiotechnology 2008, 6:4 http://www.jnanobiotechnology.com/content/6/1/4
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Quantification of the binding by MRX
The measurement is performed using a procedure and a
device described in detail by Matz et al [20]. In short, a
magnetising field of H = 2000 A/m is applied for t = 1 s.
450 µs after switching off the field, a highly sensitive low-
TC)-SQUID (Superconducting QUantum Interference
Device) sensor measures the magnetic induction B(t) at a
distance of 10 mm above the sample. The measurement
time window is 450 µs ≤ t ≤ 0.45 s. The output signals of
SQUID sensors contain an unknown offset value Boffset.
For visual comparison purposes, the offset of each meas-
ured relaxation curve B(t) was adjusted so that all relaxa-
tion curves coincide at the end of the measurement.
Note, that the relaxation signals can be measured also by
high-TC-SQUIDs [10] or by fluxgate magnetometers [21].
In the latter case the sensitivity is about 2 orders of mag-
nitude lower, but there is no need for cost intensive cool-
ing procedures. The relaxation behavior of MNP can also
be measured with magneto-optical methods as described
for example in [22].
The total magnetic moment of the sample is the sum of
the magnetic moments of all MNPs. The magnetic
moment of a single MNP can reorient within the MNP
itself by the Néel relaxation mechanism with the time
constant τN = τ0 exp{KV/kBT} [23], where τ0 = 10-10 s [24]
and K and V are the anisotropy constant and the volume
of the MNP core, respectively. If the MNP is not immobi-
lised, the magnetic moment can relax additionally via the
Brownian relaxation mechanism with the time constant
The hydrodynamic diameter of the whole particle (includ-
ing the shell) is denoted by dhyd and η is the dynamic vis-
cosity of the fluid suspension being 10-3 Pa s for water. kB
and T are the Boltzmann constant and the temperature,
respectively. Note that the effective relaxation time τeff of
unbound MNP is always shorter than that of immobilised
MNP and obeys the equation  .
The measured relaxation curve B(t) can be described as a
superposition of the relaxation curves of bound, Bb(t),
and unbound probes, Bub(t). Thus, we estimated the frac-
tion β of bound MNP by fitting the model [14]
B(t) = β Bb (t) + (1 - β) Bub (t) + Boffset (2)
to the measured relaxation curves. The difference between
relaxation times of bound and unbound MNP crucially
determines the accuracy by which the corresponding sig-
nals can be separated.
If the molecules to be quantified are comparatively small
in comparison to the probes, i.e. the MNP-labelled detec-
tion molecules, then the binding of the analytes to the
probes does not lead to a significant slowing down of the
Brownian motion. But this slowing down is necessary for
a sensitive quantification of the analyte. Therefore, in our
preparation the analyte was coupled to agarose beads
being much larger (d ≈ 5 µm) than the probes. After the
probes became bound to these analyte-beads via the
detection molecules, the Brownian relaxation time of the
probe-bead conjugates attains values of τB ≈ 400 s accord-
ing to (1). This is orders of magnitude more than τB ≈ 2 ms
which is measured for free probes (see below). Because
this time is far beyond the upper limit of our observation
time tm,max = 0.45 s, the MNP appear immobilized in our
measurement. Thus, for the estimation of the amount of
bound MNP by means of (2) we can use the relaxation
curve of freeze dried MNP as the reference data for Bb(t).
Binding kinetics
Generally, one is interested in the binding kinetics
between analyte and detection molecules. However, in
marker based assays, the kinetics of the detection mole-
cules including the marker is measured. (Note, that there
are other assays working without markers e.g. SPR.)
Caused by the markedly reduced diffusion of labelled
streptavidin due to the large size of the MNP-marker in
the present case, we expect a slower reaction than for
assays which use smaller markers, e.g. dyes. This reduction
has to be accounted for in order to compare our results
with those of other methods.
In the following we describe the binding reaction between
the probes and the binding sites (the analytes) of the aga-
rose beads which is realised by the coupling between
detection molecules and the analyte molecules. The reac-
tion between probes and binding sites, denoted by P and
B respectively, writes
The association rate and the dissociation rate constants
ka,P and kd,P, respectively, describe the kinetics of the bind-
ing of the probes (MNP-detection molecule complex).
The symbols ka and kd stands for the rate constants of the
naked molecules alone.
According to our experimental conditions, we treat the
case where the concentration of the probes exceeds that of
the targets, i.e. the concentration of the agarose beads (see
Table 3). Then, the increase in number of reaction prod-
ucts (PB), dnPB, in a small time interval dt is proportional
to the actual concentration cP of unbound probes (P) in
τπ η Bh y d B    = dk T
3 2 /( ). (1)
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the vicinity of the targets and the maximal number of
bounds nPB,max which can be realised:
dnPB = ka,P cP nPB,max dt.( 4 )
In the same time interval, according to (3), the same
amount of PB-complexes,
dnPB = kd,P nPB dt,( 5 )
dissociates. Assuming that the kinetics is purely diffusion
driven (far from mass transport regime), the concentra-
tion of the probes is homogeneous within the sample vol-
ume and writes
cP (t) = cP,0 - cPB (t). (6)
In the given situation, the total number of the binding
sites B of the multivalent target entities (agarose beads)
exceeds the number of the probes in the samples strongly
(see methodical section). Therefore, the maximal number
of bounds nPB,max which can be realised is equal to the ini-
tial number of probes nP,0. Thus, the combination of (4),
(5) and (6) yields the differential equation describing the
evolution of the concentration cPB = nPB/V (V-sample vol-
ume) to be
The solution of (7) writes
·(1 - exp{-(ka,P cP,0 + kd,P)t}). (9)
If the dissociation rate kd,P is much less then the binding
rate ka,P cP,0, the solution of (7) simplifies to
cPB (t) = cP,0 (1 - exp{-ka,P cP,0 t}). (10)
In this case, the association rate constant can be calculated
straight forward to be
ka,P = (cP,0 tb)-1 (11)
where tb is the binding time at which the (1-1/e) part of
the number of bindings at saturation is realised.
Eventually, we are interested in the kinetics of the unla-
belled biomolecules. As mentioned above, the association
rate constant of the probes is expected to be smaller in
comparison to that of unlabelled detection molecules due
to the large size of the marker. If we want to infer from the
association rate constants of the probes to that of the
naked detection molecules, we have to take into account
their different diffusion constants D ∝   where  rhyd is
the hydrodynamic radius. Thus, the association rate con-
stant of unlabeled molecules calculates
ka = κ ka,P,( 1 2 )
where κ = rhyd,P/thyd. In this approximation the reduction
of the rotational diffusion coefficient Drot ∝   was not
taken into account. This latter effect should be strong only
if the surface of MNP is sparsely covered by binding mol-
ecules.
Experimental
We investigated the binding between biotin as the analyte
and the detection biomolecules streptavidin and anti-
biotin antibody using a bead based MARIA. As described
above, the measurement signal is generated by immobili-
zation of the MNP being the labels of streptavidin (SAV)
and anti-biotin antibody (AB) by their binding to the
biotin which is linked to agarose beads.
Materials
Biotin-agarose was purchased from Sigma-Aldrich (Ger-
many), order No: B 0519 and has a binding capacity of
20–30 mg/ml avidin, i.e. 0.3–0.5 mmol/l. The diameter of
the beads is about 5 µm. Streptavidin and anti-biotin anti-
body, both labelled by MNP, were purchased from
Miltenyi Biotec (Bergisch-Gladbach, Germany). We will
refer to them further as MNP*SAV (Streptavidin-linked
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Table 3: Concentrations and size parameters of the probes and biotin-agarose beads.
Bead concentration
Samples Volume concentration of magnetite cV Mean bead diameter   nm Stock susp. c pmol/1 Meas. samples c pmol/1
biotin-agarose 5000 0.85 0.19
MNP*SAV 1.5·10-4 50 58721 6525/1958
MNP*AB 1.7·10-3 50 680190 22670/2267
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biotin-antibody-linked MicroBeads, order No: 130-090-
485), respectively (Table 3). For the binding experiments
in different media we used an other sample of MNP-
labelled streptavidin, referred to as MNP*SAV2 (Streptavi-
din-linked MicroBeads, order No: 130-074-101).
The suspension media for the binding reactions are phos-
phate buffered saline (PBS) and human serum (Sigma-
Aldrich, order No: B 0519) for the measurements of the
influence of suspension medium.
Binding experiments
The binding experiments were performed as follows: The
biotin-agarose beads were washed 3 times with PBS to
eliminate residues of free biotin which would saturate the
MNP*SAV and MNP*AB probes. We diluted the stock sus-
pension of biotin-agarose by a factor of 3 with PBS. The
MNP*SAV were diluted with PBS by factors of 3 and 10;
MNP*AB were diluted by factors of 10 and 100. For the
MARIA-measurement we filled 100 µl biotin-agarose in a
polystyrene-well (BreakApart-wells, Nunc GmbH &
Co.KG, Germany). Then, we added 50 µl of the MNP*SAV
or MNP*AB suspension. The final concentrations of
MNP*SAV, MNP*AB and agarose beads in the 150 µl
measurement volume are listed in Table 3. After gently
mixing we measured the magnetic relaxation.
Because the agarose have slightly higher density (ρ = 1.27
g/cm3) than water, the beads tend to sediment. However,
because one measurement is done after about 5 s, this sed-
imentation does not effect the measurement significantly.
For the control experiment we incubated MNP*SAV and
MNP*AB suspensions with free biotin with a concentra-
tion of c ≈ 30 µmol/l for about 3 hours at room tempera-
ture (22°C). The high biotin excess should saturate the
biotin binding sites of streptavidin and antibiotin-anti-
body. With this saturated suspensions we repeated the
binding experiments as before. In order to measure the
binding kinetics, we estimated the fraction of bound
MNP*SAV and MNP*AB at different times tI after the
incubation was launched by fitting (2) to the relaxation
curves.
Because the size of the beads reaches the µm-range and
they have a slightly higher density than water, the beads
tend to sediment due to gravity forces. Therefore, we
investigated, how the treatment of the samples during the
binding reaction determines the kinetics. In the first set of
experiments, the samples were in rest between each single
relaxation measurement. Only before each measurement,
the samples were shaken once to obtain a homogeneous
distribution of the agarose beads, because the measure-
ment signal depends on the sample detector spacing. In
the second set of experiments, the samples were rotated
slowly between the measurements, providing a continu-
ous stirring of the agarose.
In order to examine the influence of the suspension
medium on the binding reaction, we repeated the binding
experiments as described above substituting PBS by
human serum.
Because of the sedimentation tendency of the agarose
beads, the homogeneity of the sample gets lost after a cou-
ple of seconds. But due to the short measurement time of
only 5 seconds, this has no impact to the given results. In
the case of longer measurement cycles, e.g. short time
kinetics measurement, there is a need of sample stirring
preventing the sedimentation of the beads.
Appendix
We describe the kinetics for the binding of magnetic
probes to beads, β(tI), by a model, developed earlier for
analysing the kinetics of the binding of electrically
charged MNP to oppositely charged latex beads [14]. The
model bases on the diffusion driven collision theory of
Smoluchowski [25]. In this model only bindings between
elements of different  components, namely the probes
denoted by P, and binding sites of the beads, denoted by
B, are taken into account.
The number density cP (t) of probes, which are unbound
at the time t, obeys the differential equation [14]:
where αi is the collision parameter and DP is the diffusion
constant of the probes. The total concentration of binding
sites cB (0) which are accessible by ligands is related to that
of the agarose beads by cB (0) =   where dA and cA
are the diameter and the concentration of the agarose
beads, respectively. The dimensionless parameter αF rep-
resents the fraction of the surface area of the beads which
can be covered by specific binding probes at most.
As the binding goes on, the surface of the agarose beads
becomes more and more covered by the probes and the
concentration of unoccupied biotin targets cB  (t)
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and the cross section area of the probes,  , and
the cross section of collision between probes and agarose
beads, q = π (dP + dA)2, where dP is the overall diameter of
the probes. DA is the diffusion constant of the agarose
beads. The binding parameter αB describes the probability
that a collision between probes and agarose results in a
binding.
Equation 14 describes the disappearance of unbound
probes. Thus, the amount of bound probes β (see equa-
tion 2) writes
β(t)/βmax corresponds to cPB (t)/cP,0 in equation 10. βmax is
the maximal fraction of probes which can bound to agar-
ose beads. It is determined by the fraction of MNP which
are grafted by detection molecules in the proper orienta-
tion making a binding possibly. If the dissociation rate
constant kd is not negligibly, βmax is also determined by the
position of the equilibrium of the reaction.
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